EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Integrated in-silico investigation of pyrazolo[1,5-a]pyrimidine scaffolds as novel PIM-1 kinase inhibitor

Amena Ali

Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100600

DOI: 10.1016/j.lddd.2026.100600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Amena Ali. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Taif University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To identify the key structural and pharmacophoric features required for PIM-1 kinase inhibition with discovery of new PIM-1 kinase inhibitors based on pyrazolo[1,5-a]pyrimidine scaffolds by a combined computational drug discovery approach. Pharmacophore modeling and atom based 3D-QSAR analysis was performed on a dataset of 48 pyrazolo[1,5-a]pyrimidine derivatives. The validated pharmacophore model was used for virtual screening of the ZINC database. Molecular docking, R-group enumeration, molecular dynamics (MD) simulations, MM-GBSA calculations and ADME prediction were further performed to evaluate the identified compounds. Maximum survival score (5.4927) was obtained for the pharmacophore hypothesis of DDRRR_1. The best 3D-QSAR model with PLS factor 4 exhibited R² value of 0.8905 and Q² value of 0.8129. Compound 11c had the highest XP docking score of the tested analogs (-9.482 kcal/mol) with important interactions with Asp128 and Gln127. Virtual screening resulted in the identification of ZINC65030171 and ZINC72156527 with XP docking scores of -8.385 and -8.278 kcal/mol, respectively. Among the R-group enumerated compounds, A1 showed the highest XP docking score (-10.778 kcal/mol) and the most favorable MM-GBSA binding energy (-45.93 kcal/mol). MD simulations revealed that ZINC65030171 was stable in both structure and position similar to the reference ligand, while ZINC72156527 showed moderate flexibility. The integrated computational approach identified key structural features of pyrazolo[1,5-a]pyrimidine derivatives in complex with PIM-1 kinase. ZINC65030171 and the listed compounds A1 and A2 are promising computational hits for further experimental study as potential PIM-1 kinase inhibitors.

Förderung

  • Taif University

Zitieren

APA

Ali, A. (2026). Integrated in-silico investigation of pyrazolo[1,5-a]pyrimidine scaffolds as novel PIM-1 kinase inhibitor. Letters in Drug Design & Discovery, 23(9), 100600. https://doi.org/10.1016/j.lddd.2026.100600

Vancouver

Ali A. Integrated in-silico investigation of pyrazolo[1,5-a]pyrimidine scaffolds as novel PIM-1 kinase inhibitor. Letters in Drug Design & Discovery. 2026;23(9):100600. doi:10.1016/j.lddd.2026.100600

BibTeX
@article{Ali2026,
  author = {Ali, Amena},
  title = {Integrated in-silico investigation of pyrazolo[1,5-a]pyrimidine scaffolds as novel PIM-1 kinase inhibitor},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {9},
  pages = {100600},
  doi = {10.1016/j.lddd.2026.100600}
}
Kostenlos starten →